Nurix Therapeutics (NRIX)
US Market

Nurix Therapeutics (NRIX) Financial Statements


Nurix Therapeutics Financial Overview

Nurix Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.648; its P/E ratio is -5.12; Nurix Therapeutics is scheduled to report earnings on April 10, 2024, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.
Nov 23Aug 23May 23Feb 23Nov 22
Income Statement-
Total Revenue$ 15.16M$ 18.47M$ 30.68M$ 12.69M$ 6.78M
Gross Profit$ 15.16M$ 18.47M$ 30.68M$ 12.69M-
EBIT$ -41.96M$ -36.98M$ -24.28M$ -40.73M$ -48.69M
EBITDA$ -40.20M$ -35.24M$ -21.93M$ -38.37M$ -45.65M
Net Income Common Stockholders$ -41.96M$ -36.98M$ -24.28M$ -40.73M$ -46.72M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 54.63M$ 258.85M$ 281.18M$ 277.15M$ 309.14M
Total Assets$ 355.60M$ 308.19M$ 350.62M$ 370.15M$ 416.76M
Total Debt$ 30.61M$ 8.00M$ 9.34M$ 10.66M$ 11.96M
Net Debt$ -24.01M$ -250.85M$ -271.84M$ -266.48M$ -297.18M
Total Liabilities$ 155.10M$ 74.38M$ 90.70M$ 96.10M$ 113.06M
Stockholders Equity$ 200.49M$ 233.86M$ 259.88M$ 274.05M$ 303.70M
Cash Flow-
Free Cash Flow$ 24.10M$ -43.59M$ -19.55M$ 901.00K$ -40.52M
Operating Cash Flow$ 26.69M$ -41.13M$ -18.47M$ 901.00K$ -37.95M
Investing Cash Flow$ -14.37M$ 22.77M$ 43.83M$ 16.07M$ 55.01M
Financing Cash Flow$ 7.00K$ 1.70M$ 25.00K$ 1.48M$ -135.00K
Currency in USD

Nurix Therapeutics Earnings and Revenue History

Nurix Therapeutics Debt to Assets

Nurix Therapeutics Cash Flow

Nurix Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis